Pharmacological research on addictions: A framework for ethical and policy considerations

Journal of Psychoactive Drugs

Volumn 41, Issue 1, 2009, Pages 49-60

  Geppert, Cynthia ^a   Bogenschutz, Michael P ^b  

^a UNIVERSITY OF NEW MEXICO   (United States)

^b UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

Ethics; Policy; Psychopharmacology; Research; Substance use disorders

Indexed keywords

ARTICLE; CLINICAL RESEARCH; COMPENSATION; DRUG DEPENDENCE; FEMALE; HUMAN; INFORMED CONSENT; METHODOLOGY; POLICY; PROFESSIONAL STANDARD; PSYCHOPHARMACOLOGY; RESEARCH ETHICS; RESEARCH SUBJECT; RISK BENEFIT ANALYSIS; SAFETY; SAMPLING; SOCIAL PSYCHOLOGY; SUBSTANCE ABUSE; VALIDATION PROCESS; WOMEN'S RIGHTS;

EID: 65649104088     PISSN: 02791072     EISSN: 21599777     Source Type: Journal    
DOI: 10.1080/02791072.2009.10400674     Document Type: Article

References (96)

1. Adler, M.W. 1995. Human subject issues in drug abuse research. College on Problems of Drug Dependence. Drug and Alcohol Dependence 37(2):167-75.
2. Ainslie, G. 2003. Uncertainty as wealth. Behavioral Processes 64 (3): 369-385.
3. American Psychiatric Association 2000. Diagnostic and Statistical Manual of Mental Disorders Text Revision. Washington DC: American Psychiatric Press.
4. Anderson, E.E. & DuBois, J.M. 2007. The need for evidence-based research ethics: A review of the substance abuse literature. Drug and Alcohol Dependence 86 (2-3): 95-105.
5. Angelini, M. & Brahmbhat, Y. 2007. A review of the pharmacologic options fo the treatment of alcohol dependence. Formulary 42: 14-31.
6. Anton, R.F.; O'Malley, S.S.; Ciraulo, D.A.; Cisler, R.A.; Couper, D.; Donovan, D.M.; Gastfriend, D.R.; Hosking, J.D.; Johnson, B.A.; LoCastro, J.S.; Longabaugh, R.; Mason, B.J.; Mattson, M.E.; Miller, W.R.; Pettinati, H.M.; Randall, C.L.; Swift, R.; Weiss, R.D.; Williams, L.D. & Zweben, A. 2006. Combined pharmacotherapies and behavioral interventions for alcohol dependence: The COMBINE study: a randomized controlled trial. Journal of the American Medical Association 295 (17): 2003-17.
7. Appelbaum, P.S.; Grisso, T.; Frank, E.; O’Donnell, S. & Kupfer, D.J. 1999. Competence of depressed patients for consent to research. American Journal of Psychiatry 156 (9): 1380-4.
8. Beauchamp, T.L. & Childress, J.F. 2001. Principles of Biomedical Ethics. New York: Oxford University Press.
9. Block, R.I.; Erwin, W.J. & Ghoneim, M.M. 2002. Chronic drug use and cognitive impairments. Pharmacology, Biochemistry and Behavior 73 (3): 491-504.
10. Brandon, T.H. & Lisman, S.A. 2000. Introduction to the special section on empirical underpinnings of the ethics of alcohol administration in research settings. Psychology of Addictive Behaviors 14 (4): 315-8.
11. Bretteville-Jensen, A.L. 1999. Addiction and discounting. Journal of Health Economics 18 (4): 393-407.
12. Buchanan, D.; Khoshnood, K.; Stopka, T.; Shaw, S.; Santelices, C. & Singer, M. 2002. Ethical dilemmas created by the criminalization of status behaviors: Case examples from ethnographic field research with injection drug users. Health, Education and Behavior 29 (1): 30-42.
13. Carpenter, W.T., Jr.; Gold, J.M.; Lahti, AC.; Queern, C.A.; Conley, R.R.; Bartko, J.J.; Kovnick, J. & Appelbaum, P.S. 2000. Decisional capacity for informed consent in schizophrenia research [see comments]. Archives of General Psychiatry 57 (6): 533-8.
14. Charland, L.C. 2002. Cynthia's dilemma: Consenting to heroin prescription. American Journal of Bioethics 2 (2): 37-47.
15. Cohen, P.J. 2002. Untreated addiction imposes an ethical bar to recruiting addicts for non-therapeutic studies of addictive drugs. Journal of Law, Medicine & Ethics 30 (1): 73-81.
16. Cohen, P.J. 1997. Immunization for prevention and treatment of cocaine abuse: legal and ethical implications. Drug andAlcohol Dependence 48 (3): 167-74.
17. College on Problems of Drug Dependency. 1996. College on Problems of Drug Dependency policy on administering drugs with abuse potential in human research. RB 18 (5): 5-7.
18. Department ofHealth and Human Services (DHHS). 2005. Code of Federal Regulations, Title 45: Public Welfare. Part 46: Protection of Human Subjects Regulation Governing Protections Afforded Children in Research, revised June 23.
19. Department ofHealth and Human Services (DHHS). 1991. Code of Federal Regulations, Title 45: Public Welfare.Part 46: Protection of Human Subjects (Subpart C). Washington DC.
20. DeVille, K.A. & Kopelman, L.M. 1998. Moral and social issues regarding pregnant women who useandabuse drugs. Obstetrics and Gynecological Clinics of North America 25 (1): 237-54.
21. Dolinsky, Z.S. & Babor, T.F. 1997. Ethical, scientific and clinical issues in ethanol administration research involving alcoholics as human subjects. Addiction 92 (9): 1087-97.
22. Drobes, D.J. & Anton, R.F. 2000. Drinking in alcoholics following an alcohol challenge research protocol. Journal of Studies on Alcohol 61 (2): 220-4.
23. Dunn, L.B.; Lindamer, L.A.; Palmer, B.W.; Schneiderman, L.J. & Jeste, D.V. 2001. Enhancing comprehension of consent for research in older patients with psychosis: A randomized study of a novel consent procedure. American Journal of Psychiatry 158 (2): 1911-3.
24. Emanuel, E.J.; Wendler, D. & Grady, C. 2000. What makes clinical research ethical? Journal of the American Medical Association 283 (20): 2701-2.
25. Festinger, D.S.; Marlowe, D.B.; Croft, J.R.; Dugosh, K.L.; Mastro, N.K.; Lee, P.A.; Dematteo, D.S. & Patapis, N.S. 2005. Do research payments precipitate drug use or coerce participation? Drug and Alcohol Dependence 78 (3): 275-81.
26. Fischman, M.W. & Johanson, C.E. 1998. Ethical and practical issues involved in behavioral pharmacology research that administers drugs of abuse to human volunteers. Behavioral Pharmacology 9 (7): 479-98.
27. Fry, C. 2002. Raising the profile of human research ethics in addictions research: A key role for addictions journals. Addiction 97 (2): 229-30.
28. Fry, C. & Dwyer, R. 2001. For love or money? An exploratory study of why injecting drug users participate in research. Addiction 96 (9): 1319-25.
29. Fry, C.L.; Hall, W.; Ritter, A. & Jenkinson, R. 2006. The ethics of paying drug users who participate in research: A review and practical recommendations. Journal of Empirical Research on Human Research Ethics 1 (4): 21-36.
30. Garbutt, J.C.; Kranzler, H.R.; O’Malley, S.S.; Gastfriend, D.R.; Pettinati, H.M.; Silverman, B.L.; Loewy, J.W. & Ehrich, E.W. 2005. Efficacy and tolerability of long-acting injectable naltrexone for alcohol dependence: A randomized controlled trial. Journal of the American Medical Association 293 (13): 1617-25.
31. Goldman, M.S. 2000. The culture of science and the ethics of alcohol administration in research. Psychology of Addictive Behaviors 14 (4): 335-41.
32. Goldstein, R.Z. & Volkow, N.D. 2002. Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex. American Journal of Psychiatry 159 (10): 1642-52.
33. Gorelick, D.A.; Pickens, R. & Bonkovsky, H.L. 1999. Clinical research in substance abuse: Human subjects issues. In: H. Pincus; J. Lieberman & S. Ferris (Eds.) Ethics in Psychiatric Research: A Resource Manual for Human Subjects Protection. Washington DC: American Psychiatric Press.
34. Hall, W.; Carter, L. & Morley, K.l. 2004. Neuroscience research on the addictions: A prospectus for future ethical and policy analysis. Addictive Behaviors 29 (7): 1481-95.
35. Hall, W.; Carter, L. & Morley, K.l. 2003. Addiction, neuroscience and ethics. Addiction 98 (7): 867-70.
36. Harwood, H.J.; Fountain, D. & Livermore, G. 1998. Economic costs of alcohol abuse and alcoholism. Recent Developments in Alcoholism 14: 307-30.
37. Howard, J. & Beckwith, L. 1996. Issues in subject recruitment and retention with pregnant and parenting substance-abusing women. In: E. Rahdert (Ed.) Treatmentfor Drug-Exposed Women and Children: Advances in Research Methodology. NIDA Research Monograph 166. Rockville, MD: NIDA.
38. Jacob, T. & Leonard, K. 1991. Experimental drinking procedures in the study of alcoholics and their families: A consideration of ethical issues. Journal of Consulting and Clinical Psychology 59 (2): 249-55.
39. James, D.J. & Glaze, L.E. 2006. Mental Health Problems of Prison and Jail Inmates: Bureau of Justice Special Report. Washinton, DC: Bureau of Justice Staistics.
40. Johnson, B.A. 2008. Update on neuropharmacological treatments for alcoholism: Scientific basis and clinical findings. Biochemical Pharmacology 75 (1): 34-56.
41. Kantak, K.M. 2003. Vaccines against drugs of abuse: A viable treatment option? Drugs 63 (4): 341-52.
42. Karlawish, J.H.; Casarett, D.J. & James, B.D. 2002. Alzheimer’s disease patients’ and caregivers’ capacity, competency, andreasons to enroll in an early-phase Alzheimer's disease clinical trial. Journal of the American Geriatric Society 50 (12): 2019-24.
43. Katz, J. 1996. The Nuremberg Code andthe Nuremberg Trial A reappraisal. Journal of the American Medical Association 276(20): 1662-6.
44. Kessler, R.C.; Chiu, W.T.; Demler, O.; Merikangas, K.R. & Walters, E.E. 2005. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Archives of General Psychiatry 62 (6): 617-27.
45. Kleber, H.D. 1989. Drug abuse liability testing: Human subjects issues. In: M.W. Fischman & A.M. Mellow (Eds.) Assessing the Abuse Liability of Drugs in Humans. Washington, D.C.: US Government Printing Office.
46. Kleiman, M. 2003. The ‘brain disease' idea, drug policy and research ethics. Addiction 98 (7): 871-2.
47. Kleinman, I.; Schachter, D.; Jeffries, J. & Goldhamer, P. 1996. Informed consent and tardive dyskinesia. Long-term follow-up. Journal of Nervous and Mental Diseases 184 (9): 517-22.
48. Koob, G.F. 2000. Neurobiology of addiction. Toward the development of new therapies. Annals of the New York Academy of Sciences 909: 170-85.
49. Koocher, G.P. 1991. Questionable methods in alcoholism research. Journal of Consulting and Clinical Psychology 59 (2): 246-8.
50. Kranzler, H.R.; Dolinsky, Z. & Kaplan, R.F. 1990. Giving ethanol to alcoholics in a research setting: Its effect on compliance with disulfiram treatment. British Journal of Addiction 85 (1): 119-23.
51. Lindsey, K.P.; Gatley, S.J. & Volkow, N.D. 2003. Neuroimaging in drug abuse. Current Psychiatry Reports 5 (5): 355-61.
52. Link, B.G.; Struening, E.L.; Rahav, M.; Phelan, J.C. & Nuttbrock, L. 1997. On stigma and its consequences: Evidence from a longitudinal study of men with dual diagnoses of mental illness and substance abuse. Journal of Health and Social Behavior 38 (2): 177-90.
53. Lobmaier, P.; Komor, H.; Kunoe, N. & Bjorndal, A. 2008. Sustained-release naltrexone for opioid dependence. Cochrane Database Syst Rev (2):6100-6140.
54. Marlowe, D.B. 2006. Depot naltrexone in lieu of incarceration: A behavioral analysis of coerced treatment for addicted offenders. Journal of Substance Abuse Treatment 31 (2): 131-9.
55. McCance-Katz, E.F.; Kosten, T.R. & Jatlow, P. 1998. Concurrent use of cocaine and alcohol is more potent and potentially more toxic than use of either alone-a multiple-dose study. Biological Psychiatry 44 (4): 250-9.
56. McCrady, B.S. & Bux, D.A., Jr. 1999. Ethical issues in informed consent with substance abusers. Journal of Consulting and Clinical Psychology 67 (2): 186-93.
57. Miller, N.S. & Goldsmith, R.J. 2001. Craving for alcohol and drugs in animals and humans: Biology and behavior. Journal of Addictive Diseases 20 (3): 87-104.
58. Mintzer, M.Z. & Stitzer, M.L. 2002. Cognitive impairment in methadone maintenance patients. Drug and Alcohol Dependence 67 (1): 41-51.
59. Modell, J.G.; Glaser, F.B. & Mountz, J.M. 1993. The ethics and safety of alcohol administration in the experimental setting to individuals who have chronic, severe alcohol problems. Alcohol and Alcoholism 28 (2): 189-97.
60. Montoya, I.D. & Haertzen, C. 1994. Reduction of psychopathology among individuals participating in non-treatment drug abuse residential studies. Journal of Addictive Diseases 13 (2): 89-97.
61. Moser, D.J.; Schultz, S.K.; Sradt, S.; Benjamin, M.L.; Fleming, F.W.; Brems, C.S.; Paulsen, J.S.; Appelbaum, P.S. & Andreasen, N.C. 2002. Capacity to provide informed consent for participation in schizophrenia and HIV research. American Journal of Psychiatry 159 (7): 1201-7.
62. National Advisory Council on Alcohol Abuse and Alcoholism. 2005. Recommended Council Guidelines on Ethyl Alcohol Administration in Human Experimentation. Rockville, MD: National Institute on Alcohol Abuse and Alcoholism.
63. National Advisory Council on Drug Abuse. 2000. Recommended Guidelines for the Administration of Drugs to Human Subjects-Revised 2000. Rockville, MD: National Institute on Drug Abuse.
64. National Advocates for Pregnant Women. 2006. What's Wrong with Making it a Crime to be Pregnant and to have a Drug Problem. New York: National Advocates for Pregnant Women.
65. National Advocates for Pregnant Women. 2004. Facts about Drug Treatment. New York: National Advocates for Pregnant Women
66. National BioethicsAdvisory Commission. 1998. Research Involving Subjects with Mental Disorders that May Affect Decisionmaking Capacity. Rockville, MD: National Bioethics Advisory Commission.
67. National Coalition for Effective Drug Policies. 2004. The Effective National Drug Control Strategy 1999. National Coalition for Effective Drug Policies.
68. National Commission forthe Protection ofHuman Subjects ofBiomedical and Behavioral Research. 1979. The Belmont Report: Ethical Principles and Guidelines for the Protection ofHuman Subjects of Research. Washington, DC: US Government Printing Office.
69. National Institute on Alcohol Abuse and Alcoholism (NIAAA). 2004. Certificates of Confidentiality (NIAAA-Specific): Protecting the Identity ofReseach Subjects. Rockville, MD: National Institute on Alcohol Abuse and Alcoholism.
70. Office of National Drug Control Policy (ONDCP). 2004. The Economic Costs of Drug Abuse in the United States I992-2002. Washington DC: ONDCP.
71. Palmer, B.W.; Dunn, L.B.; Appelbaum, P.S.; Mudaliar, S.; Thal, L.; Henry, R.; Golshan, S. & Jeste, D.V. 2005. Assessment of capacity to consent to research among older persons with schizophrenia, Alzheimer disease, or diabetes mellitus: Comparison of a 3-item questionnaire with a comprehensive standardized capacity instrument. Archives of General Psychiatry 62 (7): 726-33.
72. Paltrow, L.M.; Cohen, D.S. & Carey, C.A. 2000. Governmental Responses to Pregnant Women who use Alcohol or Other Drugs. Philadephia PA: Women's Law Project and National Advocates for Pregnant Women.
73. Perneger, T.V.; Giner, F.; del Rio, M. & Mino, A. 1998. Randomized trial of heroin maintenance programme foraddicts who fail in conventional drug treatments. British Medical Journal 317(7150): 13-8.
74. Rawson, R.A.; McCann, M.J.; Hasson, A.J. & Ling, W. 2000. Addiction pharmacotherapy 2000: New options, new challenges. Journal of Psychoactive Drugs 32 (4): 371-8.
75. Roberts, L.W. 2002. Informed consent and the capacity for voluntarism. American Journal of Psychiatry 159 (5): 705-12.
76. Roberts, L.W. 1999. Ethical dimensions of psychiatric research: A constructive, criterion-based approach to protocol preparation. The Research Protocol Ethics Assessment Tool (RePEAT). Biological Psychiatry 46 (8): 1106-19.
77. Roberts, L.W. & Dunn, L.B. 2003. Ethical considerations in caring for women with substance use disorders. Obstetrics and Gynecological Clinics of North America 30 (3): 559-82.
78. Robins, L.N.; Helzer, J.E. & Davis, D.H. 1975. Narcotic use in southeast Asia and afterward. An interview study of 898 Vietnam returnees. Archives of General Psychiatry 32 (8): 955-61.
79. Robins, L.N. & Slobodyan, S. 2003. Post-Vietnam heroin use and injection by returning US veterans: Clues to preventing injection today. Addiction 98 (8): 1053-60.
80. Rothfleisch, J.; Elk, R.; Rhoades, H. & Schmitz, J. 1999. Use of monetary reinforcers by cocaine-dependent outpatients. Journal of Substance Abuse Treatment 17 (3): 229-36.
81. Simon, S.L.; Domier, C.P.; Sim, T.; Richardson, K.; Rawson, R.A. & Ling, W. 2002. Cognitive performance of current methamphetamine and cocaine abusers. Journal of Addictive Diseases 21 (1): 61-74.
82. Sofuoglu, M. & Kosten, T.R. 2006. Emerging pharmacological strategies in the fight against cocaine addiction. Expert Opinions on Emerging Drugs II (1): 91-8.
83. Solowij, N.; Stephens, R.S.; Roffman, R.A.; Babor, T.; Kadden, R.; Miller, M.; Christiansen, K.; McRee, B. & Vendetti, J. 2002. Cognitive functioning of long-term heavy' cannabis users seeking treatment. Journal of the American Medical Association 287 (9): 1123-31.
84. Tamkin, A.S. & Dolenz, J.J. 1990. Cognitive impairment in alcoholics. Perceptual and Motor Skills 70 (3 Pt 1): 816-8.
85. Tucker, J.A. & Vuchinich, R.E. 2000. Creating a research context for reducing risk and obtaining informed consent in human alcohol studies. Psychology of Addictive Behaviors 14 (4): 319-27.
86. Uhl, G.R. 2003. Are over-simplified views of addiction neuroscience providing too simplified ethical considerations? Addiction 98 (7): 872-3.
87. Vocci, F.J.; Acri, J. & Elkashef, A. 2005. Medication development for addictive disorders: The state of the science. American Journal of Psychiatry 162 (8): 1432-40.
88. Volkow, N.D.; Fowler, J.S. & Wang, G.J. 2003. The addicted human brain: Insights from imaging studies. Journal of Clinical Investigations 111 (10): 1444-51.
89. Vuchinich, R.E. & Simpson, C.A. 1998. Hyperbolic temporal discounting in social drinkers and problem drinkers. Experimental and Clinical Psychopharmacology 6 (3): 292-305.
90. Walters, L. & Grady, C. 2000. Bioethics issues in Neuroscience Research on Drug Abuse. Washinton of DC: National Institute on Drug Abuse: Neuroscience Constortium.
91. Wang, P.S.; Lane, M.; Olfson, M.; Pincus, H.A.; Wells, K.B. & Kessler, R.C. 2005. Twelve-month use of mental health services in the United States: Results from the National Comorbidity Survey Replication. Archives of General Psychiatry 62 (6): 629-40.
92. Wirshing, D.A.; Wirshing, W.C.; Marder, S.R.; Liberman, R.P. & Mintz, J. 1998. Informed consent: Assessment of comprehension. American Journal of Psychiatry 155 (11): 1508-11.
93. Wise, R.A. 2000. Addiction becomes a brain disease. Neuron 26 (1): 27-33.
94. Wood, M.D. & Sher, K.J. 2000. Risks of alcohol consumption in laboratory studies involving human research participants. Psychology of Addictive Behavior 14 (4): 328-34.
95. World Medical Association. 1997. World Medical Association Declaration of Helsinki. Recommendations guiding physicians in biomedical research involving human subjects [see comments]. Journal of the American Medical Association 277 (2): 925-6.
96. Zack, M. & Poulos, C.X. 2004. Amphetamine primes motivation to gamble and gambling-related semantic networks in problem gamblers. Neuropsychopharmacology 29 (1): 195-207.